BioNTech SE (BNTX) has reported an increased loss for its second quarter compared to the same period last year.
The company's net loss amounted to €807.8 million, or €3.36 per share, compared to a loss of €190.4 million, or €0.79 per share, in the second quarter of the previous year.
Revenue for the quarter saw a 23.3% decline, falling to €128.7 million from €167.7 million in the same quarter last year.
Key financial metrics (GAAP) for BioNTech SE are as follows:
- Earnings (Q2): -€807.8 million vs. -€190.4 million last year
- EPS (Q2): -€3.36 vs. -€0.79 last year
- Revenue (Q2): €128.7 million vs. €167.7 million last year
**Guidance**: The company has provided a full-year revenue forecast in the range of €2.5 billion to €3.1 billion.
